Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Guardant Health Inc (GH)

Guardant Health Inc (GH)
43.82 +0.95 (+2.22%) 13:13 ET [NASDAQ]
43.67 x 24 43.82 x 100
Realtime by (Cboe BZX)
43.67 x 24 43.82 x 100
Realtime 43.24 +0.37 (+0.86%) 09:30 ET
Quote Overview for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
42.46
Day High
45.92
Open 43.24
Previous Close 42.87 42.87
Volume 1,255,618 1,255,618
Avg Vol 2,380,338 2,380,338
Stochastic %K 36.05% 36.05%
Weighted Alpha +109.74 +109.74
5-Day Change -4.25 (-8.83%) -4.25 (-8.83%)
52-Week Range 15.81 - 50.89 15.81 - 50.89
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,291,058
  • Shares Outstanding, K 123,421
  • Annual Sales, $ 563,950 K
  • Annual Income, $ -479,450 K
  • EBIT $ -432 M
  • EBITDA $ -400 M
  • 60-Month Beta 1.32
  • Price/Sales 7.16
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 57.73% ( -0.26%)
  • Historical Volatility 78.25%
  • IV Percentile 18%
  • IV Rank 23.22%
  • IV High 95.63% on 03/07/24
  • IV Low 46.27% on 08/23/24
  • Put/Call Vol Ratio 0.56
  • Today's Volume 748
  • Volume Avg (30-Day) 2,864
  • Put/Call OI Ratio 1.56
  • Today's Open Interest 36,565
  • Open Int (30-Day) 40,906

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.72
  • Number of Estimates 4
  • High Estimate -0.62
  • Low Estimate -0.84
  • Prior Year -0.94
  • Growth Rate Est. (year over year) +23.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.79 +4.98%
on 02/10/25
Period Open: 47.21
50.89 -13.79%
on 01/30/25
-3.34 (-7.07%)
since 01/24/25
3-Month
29.91 +46.67%
on 12/30/24
Period Open: 32.65
50.89 -13.79%
on 01/30/25
+11.22 (+34.36%)
since 11/22/24
52-Week
15.81 +177.48%
on 04/19/24
Period Open: 19.42
50.89 -13.79%
on 01/30/25
+24.45 (+125.90%)
since 02/23/24

Most Recent Stories

More News
2 Stocks Down 59% and 34% to Buy and Hold

Warren Buffett, arguably the greatest investor of all time, once said it is wise for investors to be fearful when others are greedy. One way to apply this advice from the Oracle of Omaha is to look at...

GH : 43.92 (+2.45%)
ETSY : 52.75 (+2.91%)
EXAS : 51.72 (+4.99%)
ORCL : 170.71 (+1.73%)
Guardant Health Tops Q4 Revenue Forecast

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

GH : 43.92 (+2.45%)
Guardant Health: Q4 Earnings Snapshot

Guardant Health: Q4 Earnings Snapshot

GH : 43.92 (+2.45%)
Oncology Experts Predict 2025 Will Be a Year of Breakthroughs in Treatment and Prevention

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – One of the largest and most advanced cancer research and treatment organizations in the USA, City of Hope,...

ONCY : 0.7200 (-0.77%)
GH : 43.92 (+2.45%)
LEGN : 37.52 (-5.49%)
PSNL : 4.53 (-4.03%)
GRAL : 46.24 (+13.53%)
ONC.TO : 1.03 (unch)
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium

/CNW/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 in...

ONCY : 0.7200 (-0.77%)
AGEN : 3.22 (-3.01%)
GH : 43.92 (+2.45%)
XLO : 0.9364 (+0.69%)
ONC.TO : 1.03 (unch)
RNXT : 1.0175 (-1.21%)
Insider Sale: Director at $GH (GH) Sells 2,320 Shares

Musa Tariq, a director at $GH ($GH), sold 2,320 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 46.4% of their shares. Following...

GH : 43.92 (+2.45%)
Up 72% in a Month, Did You Miss the Breakout in This Russell 2000 Stock?

GH vaulted higher after a beat-and-raise quarterly report earlier this month.

GH : 43.92 (+2.45%)
Deciphering Disruption: Inside Cathie Wood's Latest Plays

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

GH : 43.92 (+2.45%)
CRSP : 47.37 (-1.13%)
TSLA : 338.02 (+0.07%)
PACB : 1.5900 (+3.25%)
TTD : 74.55 (+3.46%)
U : 27.71 (-2.22%)
MRNA : 34.34 (-3.35%)
AMZN : 214.72 (-0.86%)
COIN : 230.06 (-2.26%)
SQ : 86.96 (+0.67%)
PLTR : 93.08 (-8.16%)
ARKK : 59.79 (-0.68%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The rock star money manager is starting to roll with the rallying market.

GH : 43.92 (+2.45%)
TTD : 74.55 (+3.46%)
PACB : 1.5900 (+3.25%)
Why Guardant Health Stock Blasted 13% Higher on Thursday

There's nothing like news of a monster earnings and/or revenue beat to pump a stock's price higher. That was what happened to cancer-focused biotech Guardant Health (NASDAQ: GH) on Thursday, as its third-quarter...

GH : 43.92 (+2.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 53.99
2nd Resistance Point 51.50
1st Resistance Point 47.18
Last Price 43.92
1st Support Level 40.37
2nd Support Level 37.88
3rd Support Level 33.56

See More

52-Week High 50.89
Last Price 43.92
Fibonacci 61.8% 37.49
Fibonacci 50% 33.35
Fibonacci 38.2% 29.21
52-Week Low 15.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements